Status:
COMPLETED
The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery
Lead Sponsor:
Yanchao Yang
Conditions:
Arthroscopic Knee Surgery
Ropivacaine
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
Fast-track Surgery (FTS ) refers to the application of various proven effective methods in perioperative period to reduce stress and complications and accelerate the recovery of patients.Nowadays, FTS...
Eligibility Criteria
Inclusion
- Patients undergoing elective arthroscopic knee surgery
- ASA: grade I to III
Exclusion
- There are contraindications to spinal anesthesia
- Allergic to local anesthetics
- Patient refused
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04759742
Start Date
March 1 2021
End Date
June 1 2023
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital
Shengyang, Liaoning, China, 110000